NEW YORK, March 20, 2017 -- Golden Star Enterprises Ltd. (OTCPK:GSPT) reports that the Company has signed an Agreement with Dantas Enterprises Ltd. to buy its business known as WeeCare Wholesale Ltd. and all the assets thereof.
WeeCare Wholesale Limited is working to develop an online and offline warehouse that would provide a wide selection of legal cannabis products and accessories. The company will uniquely position itself to offer independent wholesale distribution, marketing and sales promotion of legal cannabis throughout North America where legalized. The company will take advantage of economies of scale by sourcing legal cannabis products and accessories in bulk directly from producers, cultivators and manufacturers and sell directly to the target customers using B2B and B2C methods. WeeCare Wholesale Limited will support the legal retailers with the need of one stop shop for various brands of legal cannabis products and accessories.
The Agreement calls for issuance of cash and restricted shares of Golden Star Enterprises Ltd. to complete the acquisition. We will continue our communication with shareholders in the coming weeks and months on our efforts and the potential impact of this acquisition for the Company.
Robert Klein, President of Golden Star states, “The decision for Golden Star to enter into this Agreement was made with the knowledge that the legal marijuana industry is still evolving. The WeeCare Wholesale Ltd. plan is a model that could turn something that’s so unorganized without structure into something efficient, something that is fast, easy, safe and as hassle free as possible, something where target customers can obtain legal cannabis products and accessories smoothly and efficiently.”
/s/ Robert Klein
Robert Klein, President
For further information contact: 1-888-488-6882
Visit our website at www.goldenstarent.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Golden Star’s filings with the OTC Markets.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



